Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 8Breast Neoplasms 7Uterine Cervical Neoplasms 6Uterine Cervical Dysplasia 5Persistent Infection 4Melanoma 4Glioblastoma 3Carcinoma, Non-Small-Cell Lung 3Sarcoma 2Neuroblastoma 2Lung Neoplasms 2Influenza, Human 2HIV Infections 2Glioma 2Condylomata Acuminata 2Breast Neoplasms, Male 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Spondylitis, Ankylosing 1Small Cell Lung Carcinoma 1Rheumatic Diseases 1Recurrence 1Psoriasis 1Prostatic Neoplasms 1Papillomavirus Infections 1Pancreatic Neoplasms 1Neuroectodermal Tumors, Primitive 1Neoplasms, Nerve Tissue 1

Interventions

Ipilimumab 6tremelimumab 5durvalumab 5Nivolumab 3Capecitabine 3Radiotherapy 2Radiation 2Paclitaxel 2CTLA-4 Antigen 2Blood Specimen Collection 2relatlimab 1poly ICLC 1lenvatinib 1folfirinox 1balstilimab 1Vaccines 1Vaccination 1Surgical Procedures, Operative 1Radiosurgery 1Platinum 1Peptides 1Pemetrexed 1Oxaliplatin 1Opdualag 1Monophenol Monooxygenase 1Melphalan 1Leucovorin 1Immunotherapy 1Fluorouracil 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Diabetes Mellitus, Insulin-Dependent, 12 × Vaccines × Clear all
NCT01896869 2020-05-19

FOLFIRINOX Followed by Ipilimumab With Pancreatic Tumor Vaccine in Treatment of Metastatic Pancreatic Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Completed
83 enrolled 16 charts
Gastrointestinal

Diabetes Mellitus, Insulin-Dependent, 12, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡